TABLE OF CONTENTS

Volume 31, Issue 8 (April (2) 2003)

Top

Mini Reviews

Bone marrow transplant in Ph+ ALL patients FREE

I Avivi and A H Goldstone

Bone Marrow Transplant 31: 623-632; doi:10.1038/sj.bmt.1703899

Should we be performing more combined hematopoietic stem cell plus solid organ transplants? FREE

K Y Chiang and H M Lazarus

Bone Marrow Transplant 31: 633-642; doi:10.1038/sj.bmt.1703952

Top

Conditioning Regimens

Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation FREE

R T Dorr, A Briggs, P Kintzel, R Meyers, H-HS Chow and A List

Bone Marrow Transplant 31: 643-649; doi:10.1038/sj.bmt.1703906

Top

Cytokines

Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization FREE

T Kozuka, F Ishimaru, K Fujii, K Masuda, K Kaneda, T Imai, N Fujii, H Ishikura, S Hongo, T Watanabe, K Shinagawa, K Ikeda, K Niiya, M Harada and M Tanimoto

Bone Marrow Transplant 31: 651-654; doi:10.1038/sj.bmt.1703901

Top

Breast Cancer

Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients FREE

S M Stemmer, I Hardan, H Raz, A K Adamou, M Inbar, M Gottfried, Y Merrick, Y Cohen, A Sulkes, N Ben-Baruch, R P Pfeffer, H J Brenner and S Rizel

Bone Marrow Transplant 31: 655-661; doi:10.1038/sj.bmt.1703856

Top

Mycosis Fungoides

Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen FREE

D Soligo, A Ibatici, E Berti, P Morandi, E Longhi, L Venegoni, M Corbellino, C Annaloro, L Robbiolo, A Della Volpe, E Alessi and G Lambertenghi Deliliers

Bone Marrow Transplant 31: 663-666; doi:10.1038/sj.bmt.1703872

Top

Lymphoma

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation FREE

A J Peniket, M C Ruiz de Elvira, G Taghipour, C Cordonnier, E Gluckman, T de Witte, G Santini, D Blaise, H Greinix, A Ferrant, J Cornelissen, N Schmitz and A H Goldstone on behalf of the European Bone Marrow Transplantation (EBMT) Lymphoma Registry

Bone Marrow Transplant 31: 667-678; doi:10.1038/sj.bmt.1703891

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma FREE

T Cheng, P Forsyth, A Chaudhry, D Morris, S Glück, J A Russell and D A Stewart

Bone Marrow Transplant 31: 679-685; doi:10.1038/sj.bmt.1703917

Top

Donor Lymphocyte Infusions

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions FREE

A M Raiola, M T Van Lint, M Valbonesi, T Lamparelli, F Gualandi, D Occhini, S Bregante, C di Grazia, A Dominietto, M Soracco, C Romagnani, F Vassallo, M Casini, B Bruno, F Frassoni and A Bacigalupo

Bone Marrow Transplant 31: 687-693; doi:10.1038/sj.bmt.1703883

Top

Viral Infections

Low mortality rates related to respiratory virus infections after bone marrow transplantation FREE

C M Machado, L S Vilas Boas, A V A Mendes, M F M Santos, I F da Rocha, D Sturaro, F L Dulley and C S Pannuti

Bone Marrow Transplant 31: 695-700; doi:10.1038/sj.bmt.1703900

Top

Post-Transplant Complications

The incidence, pathogenesis and natural history of steatorrhoea after bone marrow transplantation FREE

A P Grigg, P W Angus, R Hoyt and J Szer

Bone Marrow Transplant 31: 701-703; doi:10.1038/sj.bmt.1703911

A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation FREE

A S Papas, R E Clark, G Martuscelli, K T O'Loughlin, E Johansen and K B Miller

Bone Marrow Transplant 31: 705-712; doi:10.1038/sj.bmt.1703870

Top

Technical Report

Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2 FREE

M Sanchez, E Alfani, A R Migliaccio, T Bonfini and G Migliaccio

Bone Marrow Transplant 31: 713-723; doi:10.1038/sj.bmt.1703904

Top

Correspondence

Post-transplant lymphoproliferative disorders following reduced intensity conditioning with in vivo T cell depletion FREE

K S Peggs, L Banerjee, K Thomson and S Mackinnon

Bone Marrow Transplant 31: 725-726; doi:10.1038/sj.bmt.1703893

Top

Response

Response to Peggs et al.  FREE

A Y L Ho, S Devereux, A Pagliuca and G J Mufti

Bone Marrow Transplant 31: 727; doi:10.1038/sj.bmt.1703894

Top

Corrigendum

Retrospective appraisal of busulfan dose adjustment in children FREE

L L Dupuis, M Najdova and E F Saunders

Bone Marrow Transplant 31: 729; doi:10.1038/sj.bmt.1703926

Extra navigation

.
ADVERTISEMENT